DCF — ENCOMPASS HEALTH REHABIITATION HOSPI
Enterprise Value: $-24.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-24.4M
Enterprise Value
$-7.7M
PV of Cash Flows
$-16.7M
PV of Terminal Value
$-26.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $15.0M | $-1.5M | -10.0% | $-2.2M | $-2.0M |
| Year 2 | $15.4M | $-1.4M | -9.0% | $-2.1M | $-1.7M |
| Year 3 | $15.9M | $-1.3M | -8.0% | $-2.0M | $-1.5M |
| Year 4 | $16.4M | $-1.3M | -8.0% | $-2.0M | $-1.3M |
| Year 5 | $16.9M | $-1.3M | -7.0% | $-2.0M | $-1.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-24.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$14.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.106892396379181
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5